Nazik Hammad, Medical Oncologist and professor at St. Michael’s Hospital, University of Toronto, shared NCI Center for Global Health’s post on LinkedIn, adding:
“Honoured to be receiving this award today.
This award is truly honouring my colleagues and mentees I worked with over the years trying to bring change and attention to the salient problems of our time in particular in Africa from the cancer workforce, value-based cancer care in LMIC, women and cancer, women in the cancer workforce to cancer in conflict-affected populations in Africa.
I thank the NCI Centre for Global Health for their unstinting support and exceptional work to improve cancer outcomes in LMIC.
Please join for the award keynote talk.”
Quoting NCI Center for Global Health’s post:
“We are pleased to announce Nazik Hammad, as the recipient of the 2026 Pearline Award for Global Cancer Research!
Presented at the NCI Center for Global Health’s Annual Symposium on Global Cancer Research (ASGCR), the Rachel Pearline Award recognizes individuals whose outstanding contributions have advanced global cancer research and helped improve cancer prevention, care, and control worldwide.
Join us as we celebrate Dr. Hammad’s achievements and hear her keynote address, where she will share insights from her work and perspectives on advancing cancer care globally.
September 15–17, 2026
Virtual, free, and open to the public
Register.
ASGCR is hosted in collaboration with the U.S. NCI Center for Global Health for Global Health (NCI/CGH); Consortium of Universities for Global Health (CUGH); American Society of Clinical Oncology (ASCO); American Association for Cancer Research (AACR); African Organisation for Research and Training in Cancer (AORTIC- Africa); American Society of Preventive Oncology (ASPO); National Cancer Grid India (NCG); and Red de Institutos e Instituciones Nacionales de Cáncer (RINC) – Sociedad Latinoamericana y del Caribe de Oncología Médica (SLACOM).”
Other posts featuring Nazik Hammad on OncoDaily.